PL EN
Rycina z artykułu: A case of sarcoidosis...
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Sarcoidosis is a systemic granulomatous disease of unknown etiology, characterized by marked clinical heterogeneity and the absence of a single diagnostic test. It most commonly affects young adults, mainly women, and typically involves the lungs and hilar lymph nodes, although extrapulmonary organ involvement is frequently observed. We present the case of a 39-year-old man with obesity (body mass index 33.25 kg/m2), arterial hypertension, and newly diagnosed type 2 diabetes mellitus, who was hospitalized due to pain and swelling of the ankle joints and the right wrist persisting for three weeks. Empirical outpatient antibiotic therapy failed to improve the patient’s condition. Laboratory findings revealed leukocytosis with neutrophilia, markedly elevated inflammatory markers, and metabolic abnormalities. Chest imaging demonstrated bilateral hilar and mediastinal lymphadenopathy as well as subpleural fibrotic changes in segment 9 of the right lung, raising suspicion of sarcoidosis. This case highlights the wide range of clinical manifestations of sarcoidosis, emphasising the importance of a thorough diagnostic evaluation. It highlights that sarcoidosis may present predominantly with joint involvement without typical cutaneous or respiratory manifestations. Coexisting metabolic disorders may further modify the inflammatory response and obscure the classic clinical presentation. Therefore, sarcoidosis should be considered in the differential diagnosis of arthritis of unclear etiology, particularly in patients with concomitant metabolic disturbances.
Oświadczenie o wykorzystaniu narzędzi AI: Do tłumaczenia artykułu wykorzystano Gemini 3.1 Pro.
REFERENCJE (20)
1.
Piotrowski W, Rowińska-Zakrzewska E, Bestry I. Sarkoidoza. In: Gajewski P [ed.]. Interna Szczeklika 2024. Medycyna Praktyczna. Kraków 2024, p. 807–812.
 
2.
Xu D, Tao X, Fan Y, Teng Y. Sarcoidosis: molecular mechanisms and therapeutic strategies. Mol Biomed. 2025;6(1):6. doi: 10.1186/s43556-025-00244-z.
 
3.
Cooper D, Suau S. Sarcoidosis. Emerg Med Clin North Am. 2022;40(1):149–157. doi: 10.1016/j.emc.2021.08.012.
 
4.
Ungprasert P, Crowson CS, Matteson EL. Clinical characteristics of sarcoid arthropathy: A population-based study. Arthritis Care Res. 2016;68(5):695–699. doi: 10.1002/acr.22737.
 
5.
Zdrojewski Z, Wierzba K. Sarcoidosis – multisystem disorder. [Article in Polish]. Forum Reumatol. 2018;4(4):225–230. doi: 10.5603/FR.2018.0011.
 
6.
Czupryniak L. Beta‑protekcja – patofizjologiczny element terapii cukrzycy typu 2. Diabetol Prakt. 2007;8(suppl. B):B11–B15.
 
7.
Cozier YC, Govender P, Berman JS. Obesity and sarcoidosis: consequence or contributor? Curr Opin Pulm Med. 2018;24(5):487–494. doi: 10.1097/MCP.0000000000000503.
 
8.
Kobak S, Semiz H, Akyildiz M, Gokduman A, Atabay T, Vural H. Serum adipokine levels in patients with sarcoidosis. Clin Rheumatol. 2020;39(7):2121–2125. doi: 10.1007/s10067-020-04980-1.
 
9.
Cozier YC, Coogan PF, Govender P, Berman JS, Palmer JR, Rosenberg L. Obesity and Weight Gain in Relation to Incidence of Sarcoidosis in US Black Women: Data From the Black Women’s Health Study. Chest. 2015;147(4):1086–1093. doi: 10.1378/chest.14-1099.
 
10.
Poole GW. The diagnosis of sarcoidosis. Br Med J. 1982;285(6338):321–322. doi: 10.1136/bmj.285.6338.321.
 
11.
Kobak S, Sever F, Usluer O, Goksel T, Orman M. The clinical characteristics of sarcoid arthropathy based on a prospective cohort study. Ther Adv Musculoskelet Dis. 2016;8(6):220–224. doi: 10.1177/1759720X16670598.
 
12.
Ekin A, Misirci S, Sertkaya O, Coskun BN, Yagiz B, Dalkilic E, et al. Rheumatologic perspectives on sarcoidosis: predicting sarcoidosis-associated arthritis through comprehensive clinical and laboratory assessment. J Clin Med. 2024;13(24):7563. doi: 10.3390/jcm13247563.
 
13.
Kobak S. Sarcoidosis: a rheumatologist’s perspective. Ther Adv Musculoskelet Dis. 2015;7(5):196–205. doi: 10.1177/1759720X15591310.
 
14.
Yeung T, Grebowicz A, Nevskaya T, Zahid S, Pope JE. Joint involvement in sarcoidosis: systematic review and meta-analysis of prevalence, clinical pattern and outcome. Rheumatology. 2024;63(7):1803–1814. doi: 10.1093/rheumatology/keae048.
 
15.
Dey R, Kattamuri L, Chirrareddy Y, Luna Ceron E, Sharma K, Padilla O, et al. Löfgren’s syndrome: A unique presentation of sarcoidosis masquerading as lower extremity cellulitis. J Investig Med High Impact Case Rep. 2025;13:23247096251352366. doi: 10.1177/23247096251352366.
 
16.
Kucharz EJ. Osseous manifestations of sarcoidosis. Reumatologia. 2020;58(2):93–100. doi: 10.5114/reum.2020.95363.
 
17.
Ogami R, Otsuka Y, Hasegawa K, Tokumasu K, Obika M, Fujii M, et al. Acute arthritis caused by sarcoidosis. J Gen Fam Med. 2023;24(4):264–265. doi: 10.1002/jgf2.621.
 
18.
Benmelouka AY, Abdelaal A, Mohamed ASE, Shamseldin LS, Zaki MM, Elsaeidy KS, et al. Association between sarcoidosis and diabetes mellitus: a systematic review and meta-analysis. Expert Rev Respir Med. 2021;15(12):1589–1595. doi: 10.1080/17476348.2021.1932471.
 
19.
Chojnowski K. D-dimer - diagnostic and prognostic marker of venous thromboembolism. Hematol Clin Pract. 2010;1(2):102–108.
 
20.
Piotrowski WJ, Bączek K, Majewski S. Zasady leczenia sarkoidozy na podstawie wytycznych European Respiratory Society (ERS) i stanowiska British Thoracic Society (BTS). Pneum Pol. 2022;3(1–2):14–22.
 
eISSN:1734-025X
Journals System - logo
Scroll to top